|
Volumn 39, Issue 2, 2001, Pages 61-65
|
Nasal inflammation and anti-inflammatory treatment. Semantics or clinical reality?
|
Author keywords
Anti histamines; Anti inflammatory treatment; Corticosteroids; Inflammation; Rhinitis
|
Indexed keywords
ALLERGEN;
ANTIHISTAMINIC AGENT;
ANTIINFLAMMATORY AGENT;
CELL ADHESION MOLECULE;
CETIRIZINE;
CHEMOKINE;
CORTICOSTEROID;
CYTOKINE;
HISTAMINE;
VASOCONSTRICTOR AGENT;
ALLERGIC RHINITIS;
ANTIINFLAMMATORY ACTIVITY;
CLINICAL PHARMACOLOGY;
CLINICAL RESEARCH;
COMMON COLD;
COST BENEFIT ANALYSIS;
DISEASE ASSOCIATION;
DRUG EFFECT;
DRUG EFFICACY;
EOSINOPHIL;
HISTAMINE RELEASE;
HUMAN;
HYPOTHESIS;
INFLAMMATION;
LANGERHANS CELL;
MAST CELL;
MOLECULAR BIOLOGY;
NOSE MUCOSA;
PATIENT COMPLIANCE;
REVIEW;
RHINITIS;
RISK BENEFIT ANALYSIS;
SEMANTICS;
SYMPTOM;
TH2 CELL;
ADRENAL CORTEX HORMONES;
FORECASTING;
HISTAMINE H1 ANTAGONISTS;
HISTAMINE RELEASE;
HUMANS;
RHINITIS;
TERMINOLOGY;
|
EID: 0034942291
PISSN: 03000729
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (16)
|
References (30)
|